Mana.bio vs Spade Therapeutics
Mana.bio vs Spade Therapeutics, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Mana.bio is on 59/100 and Spade Therapeutics on 38/100.
Where each one leads
Mana.bio
- our overall score: 59/100 against 38/100
- agent readiness: 50/100 against 22/100
Spade Therapeutics
- funding raised: $40.0M against $19.5M
At a glance
| Measure | Mana.bio | Spade Therapeutics |
|---|---|---|
| What it is | AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies. | Drug discovery and development company using a novel technological approach. |
| Category | Life Sciences, Drug Delivery, mRNA, Lipid Nanoparticle (LNP) | Life Sciences, Drug Discovery, Drug Development, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Services |
| Founded | 2021 | 2022 |
| Headquarters | Boston, United States | Cambridge, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Mana.bio | Spade Therapeutics |
|---|---|---|
| Employees | 20 | Not published |
| Headcount growthLast 12 months | +7.2% | Not published |
| Total funding | $19.5M | $40.0M |
| Latest round | Seed | Series B |
| LinkedIn followers | 4,234 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Mana.bio | Spade Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 38/100 |
| Traction | 50/100 | 38/100 |
| Team | 90/100 | 30/100 |
| Community | 8/100 | 15/100 |
| Search visibility | 44/100 | 2/100 |
| Quality | 58/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 28/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Mana.bio | Spade Therapeutics |
|---|---|---|
| CMS | Wix | Not detected |
Mana.bio vs Spade Therapeutics: common questions
Which is better, Mana.bio or Spade Therapeutics?
On our 0-100 score Mana.bio rates higher (59/100 against 38/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Mana.bio and Spade Therapeutics compare on the numbers?
Mana.bio leads on our overall score (59/100 against 38/100), agent readiness (50/100 against 22/100). Spade Therapeutics leads on funding raised ($40.0M against $19.5M).
Read the full Mana.bio review and pricing or the Spade Therapeutics review and pricing. You can also browse other Mana.bio alternatives we track.